SCHEMBL29908856

SCHEMBL29908856

COc1cc2c(Oc3ccc(N)cc3F)ccnc2cc1OCCN1CCOCC1

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 8/20 0.92
FLT3 P36888 4/20 0.61
MET P08581 10/20 0.60
EGFR P00533 3/20 0.60
KDR P35968 3/20 0.60
MST1R Q04912 3/20 0.60
FGFR2 P21802 2/20 0.60
SRC P12931 2/20 0.60
AURKA O14965 2/20 0.60
LCK P06239 2/20 0.60
CSF1R P07333 2/20 0.60
RPS6KB1 P23443 2/20 0.60
FLT4 P35916 2/20 0.60
TEK Q02763 2/20 0.60
BTK Q06187 2/20 0.60
PLK4 O00444 1/20 0.60
STK25 O00506 1/20 0.60
CIT O14578 1/20 0.60
CHUK O15111 1/20 0.60
MUSK O15146 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591152 1.00 AXL (0.92) AXLFLT3METEGFRKDR
SCHEMBL14289192 1.00 AXL (0.92) AXLFLT3METEGFRKDR
SCHEMBL14289180 0.96 AXL (1.00) AXLFLT3METEGFRKDR
SCHEMBL166239 0.96 AXL (1.00) AXLFLT3METEGFRKDR
SCHEMBL30000966 0.96 AXL (1.00) AXLFLT3METEGFRKDR
SCHEMBL25118503 0.88 AXL (0.72) AXLFLT3METEGFRKDR
SCHEMBL15084626 0.88 AXL (0.71) AXLFLT3METEGFRKDR
SCHEMBL29631712 0.88 AXL (0.71) AXLFLT3METEGFRKDR
SCHEMBL15262000 0.87 AXL (0.85) AXLFLT3METKDRMST1R
SCHEMBL1591146 0.87 AXL (0.71) AXLFLT3METEGFRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916210-A Pharmaceutical composition for preventing or treating small cell lung cancer associated with RON mutation and method of using the same 伟迈可生物有限公司 2023-04-04 CN disclosed
EP-4154891-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NON-SMALL CELL LUNG CANCER ASSOCIATED WITH RON MUTATION, AND METHOD USING SAME Wellmarker Bio Co., Ltd. (KR) 2023-03-29 EP disclosed
EP-4154892-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SMALL-CELL LUNG CANCER ASSOCIATED WITH RON MUTANTS AND METHOD USING SAME Wellmarker Bio Co., Ltd. (KR) 2023-03-29 EP disclosed
EP-4154890-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PANCREATIC CANCER ASSOCIATED WITH RON MUTATION AND METHOD USING SAME Wellmarker Bio Co., Ltd. (KR) 2023-03-29 EP disclosed
CN-115003307-A Pharmaceutical composition for preventing or treating cancers associated with KRAS mutations 伟迈可生物有限公司 2022-09-02 CN disclosed